プラチナによるNK細胞活性化は,HR+/HER2-の乳がんにおける免疫療法を強化する
Yi-Yu Chen1, Yi-Fan Zhou1, Xuan Qi1
1Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 15, 2026
まとめ
この研究は,活性化された自然殺生細胞 (NK細胞) が,ホルモン受容体陽性乳がんにおける免疫療法の有効性にとって極めて重要であることを明らかにしています. プラチナ化学療法はNK細胞の活動を高め,免疫療法の結果を改善します.
科学分野:
- 腫瘍学 腫瘍学
- 免疫学 免疫学とは
- ゲノミクスゲノミクスとは
背景:
- 免疫療法は,ホルモン受容体陽性 (HR+) /ヒト表皮成長因子受容体2陰性 (HER2-) の乳がんにおいて,限られた成功を収めている.
- この抵抗における腫瘍マイクロ環境の役割は,完全に理解されていません.
研究 の 目的:
- HR + /HER2 - 乳がんの腫瘍マイクロ環境を調査する.
- 免疫療法への反応に影響を与える要因を特定する.
- 免疫療法の有効性を高めるための組み合わせ戦略を探求する.
主な方法:
- 大規模なマルチオミックと単細胞RNAシーケンシング (scRNA-seq) を用いて,腫瘍の微環境を分析した.
- 臨床前モデルは,NK細胞に対する免疫療法の効果を評価するために使用されました.
- 薬物スクリーニングでは,NK細胞の活性を増強する薬剤を特定しました.
- 臨床コホート分析は,NK細胞集団との治療を相関させた.
主要な成果:
- 活性化されたNK細胞の豊富さは,HR+ /HER2 - 乳がんにおける陽性抗PD-(L) 1応答と相関しています.
- 免疫療法はNK細胞の細胞毒性と免疫調節機能を強化し,臨床前モデルでは腫瘍の成長を抑制します.
- プラチナ剤は,潜在的にNF-κB経路を通じてNK細胞の細胞毒性を強化し,免疫療法との相乗効果を示しています.
- プラチナベースの化学療法は,患者の腫瘍における活性化されたNK細胞を増加させた.
結論:
- NK細胞は,HR+/HER2 - 乳がんにおける免疫療法の応答を媒介する上で重要な役割を果たします.
- プラチナ剤は,NK細胞の活性を増強することで,免疫療法の有効性を高めることができ,新しい組み合わせ戦略を提示します.
関連する概念動画
Immune Surveillance by NK Cells and Phagocytes
8.9K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
8.9K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
B Cell Activation and Differentiation
17.0K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.0K
Cancer Cell Migration through Invadopodia
3.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
T Cell Activation and Clonal Selection
16.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.4K


